Kevin Bakker

1.4k total citations · 1 hit paper
19 papers, 815 citations indexed

About

Kevin Bakker is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Kevin Bakker has authored 19 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Kevin Bakker's work include Respiratory viral infections research (9 papers), Influenza Virus Research Studies (8 papers) and Pneumonia and Respiratory Infections (4 papers). Kevin Bakker is often cited by papers focused on Respiratory viral infections research (9 papers), Influenza Virus Research Studies (8 papers) and Pneumonia and Respiratory Infections (4 papers). Kevin Bakker collaborates with scholars based in United States, United Kingdom and Spain. Kevin Bakker's co-authors include Patricia L. Yager, Connie Lovejoy, Carlos Pedrós‐Alió, Micaela E. Martinez, Pierre E. Galand, Thomas Pommier, David L. Kirchman, Elizabeth W. Maas, Alison E. Murray and Jean‐François Ghiglione and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Kevin Bakker

18 papers receiving 796 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wastewater-Based Detection of Two Influenza Outbreaks

2022 116 citations Marlene K. Wolfe, Dorothea Duong et al. Environmental Science & Technology Letters profile →

Peers

Countries citing papers authored by Kevin Bakker

Since Specialization

Citations

This map shows the geographic impact of Kevin Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Bakker more than expected).

Fields of papers citing papers by Kevin Bakker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Bakker. The network helps show where Kevin Bakker may publish in the future.

Co-authorship network of co-authors of Kevin Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Bakker. A scholar is included among the top collaborators of Kevin Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Bakker. Kevin Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Modelling the Epidemiological Impact of Different Adult Pneumococcal Vaccination Strategies in the United Kingdom 2025 ·Infectious Diseases and Therapy ·Rachel J. Oidtman, (unknown), Oluwaseun Sharomi, Ian R. Matthews, (unknown), Robert B. Nachbar, Tufail Malik, Kevin Bakker	1
2	PCV13-Serotype Breakthrough Pneumococcal Disease in Infants Receiving High-Valency Conjugate Vaccines: Population-Level Modeling in France 2025 ·Infectious Diseases and Therapy ·Kevin Bakker, Rachel J. Oidtman, Natalie Banniettis, Kristen A. Feemster, Priscilla Velentgas, Tufail Malik, (unknown), Jessica Weaver	1
3	A dynamic transmission model for assessing the impact of pneumococcal vaccination in the United States 2025 ·PLoS ONE ·Tufail Malik, Kevin Bakker, Rachel J. Oidtman, Oluwaseun Sharomi, (unknown), Robert B. Nachbar, Elamin H. Elbasha	2
4	Epidemiological Impact of Increasing Vaccination Coverage Rate and Re-Vaccination on Pneumococcal Disease in Older Adults in Germany 2025 ·Vaccines ·Oluwaseun Sharomi, (unknown), (unknown), (unknown), (unknown), (unknown), Tufail Malik, Kevin Bakker, Rachel J. Oidtman	0
5	Reduction in Long COVID Symptoms and Symptom Severity in Vaccinated Compared to Unvaccinated Adults 2024 ·Open Forum Infectious Diseases ·Hannah E. Maier, Theresa Kowalski-Dobson, Ashley Eckard, Carmen Gherasim, David M. Manthei, (unknown), (unknown), Kevin Bakker, (unknown), (unknown), (unknown), Matthew Arnold, (unknown), Emily Stoneman, Riccardo Valdez, Aubree Gordon	5
6	Norovirus GII wastewater monitoring for epidemiological surveillance 2024 ·PLOS Water ·Michelle L. Ammerman, (unknown), Julie Gilbert, (unknown), (unknown), Kevin Bakker, Marisa C. Eisenberg, Betsy Foxman, Krista R. Wigginton	10
7	Real-Time Monitoring of Infectious Disease Outbreaks with a Combination of Google Trends Search Results and the Moving Epidemic Method: A Respiratory Syncytial Virus Case Study 2023 ·Tropical Medicine and Infectious Disease ·(unknown), Andrea Guerra, Frederick Wittke, (unknown), Kevin Bakker, Andrew W. Lee, Lyn Finelli, (unknown)	10
8	Burden and seasonality of primary and secondary symptomatic common cold coronavirus infections in Nicaraguan children 2022 ·Influenza and Other Respiratory Viruses ·(unknown), Ángel Balmaseda, (unknown), Mayuri Patel, Sergio Ojeda, Andrew F. Brouwer, (unknown), Shuwei Cai, Kevin Bakker, Nery Sánchez, Roger López, Guillermina Kuan, Aubree Gordon	2
9	The Nicaraguan Pediatric Influenza Cohort Study, 2011–2019: Influenza Incidence, Seasonality, and Transmission 2022 ·Clinical Infectious Diseases ·Hannah E. Maier, Guillermina Kuan, Lionel Gresh, Gerardo Chowell, Kevin Bakker, Roger López, Nery Sánchez, Brenda López, Amy Schiller, Sergio Ojeda, Eva Harris, Ángel Balmaseda, Aubree Gordon	5
10	Leveraging infectious disease models to interpret randomized controlled trials: Controlling enteric pathogen transmission through water, sanitation, and hygiene interventions 2022 ·PLoS Computational Biology ·Andrew F. Brouwer, Marisa C. Eisenberg, Kevin Bakker, (unknown), Mondal Hasan Zahid, Matthew C. Freeman, Joseph N. S. Eisenberg	4
11	Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation 2022 ·BMC Medicine ·Kevin Bakker, Marisa C. Eisenberg, Robert J. Woods, Micaela E. Martinez	5
12	Wastewater-Based Detection of Two Influenza Outbreaks breakdown → 2022 ·Environmental Science & Technology Letters ·Marlene K. Wolfe, Dorothea Duong, Kevin Bakker, Michelle L. Ammerman, Lindsey Mortenson, Bridgette Hughes, Peter J. Arts, Adam S. Lauring, William J. Fitzsimmons, Emily E. Bendall, Calvin E. Hwang, Emily T. Martin, Bradley J. White, Alexandria B. Boehm, Krista R. Wigginton	116
13	SARS-CoV-2 RNA is enriched by orders of magnitude in primary settled solids relative to liquid wastewater at publicly owned treatment works 2022 ·Environmental Science Water Research & Technology ·Sooyeol Kim, Lauren C. Kennedy, Marlene K. Wolfe, Craig S. Criddle, Dorothea Duong, Aaron Topol, Bradley J. White, Rose S. Kantor, Kara L. Nelson, Joshua A. Steele, (unknown), John F. Griffith, Amity G. Zimmer-Faust, Sandra L. McLellan, (unknown), Michelle L. Ammerman, Krista R. Wigginton, Kevin Bakker, Alexandria B. Boehm	59
14	Exploring the Seasonal Drivers of Varicella Zoster Virus Transmission and Reactivation 2021 ·American Journal of Epidemiology ·Kevin Bakker, Marisa C. Eisenberg, Robert J. Woods, Micaela E. Martinez	10
15	Fluorescent biomarkers demonstrate prospects for spreadable vaccines to control disease transmission in wild bats 2019 ·Nature Ecology & Evolution ·Kevin Bakker, Tonie E. Rocke, Jorge E. Osorio, Rachel C. Abbott, Carlos Tello, Jorge Carrera, William Valderrama, (unknown), Néstor Falcón P., Daniel G. Streicker	29
16	Digital epidemiology reveals global childhood disease seasonality and the effects of immunization 2016 ·Proceedings of the National Academy of Sciences ·Kevin Bakker, Micaela E. Martinez, Barbara Helm, Tyler J. Stevenson	65
17	Human birth seasonality: latitudinal gradient and interplay with childhood disease dynamics 2014 ·Proceedings of the Royal Society B Biological Sciences ·Micaela E. Martinez, Kevin Bakker, Aaron A. King, Pejman Rohani	52
18	Role for urea in nitrification by polar marine Archaea 2012 ·Proceedings of the National Academy of Sciences ·Laura Alonso‐Sáez, Alison S. Waller, Daniel R. Mende, Kevin Bakker, Hanna Farnelid, Patricia L. Yager, Connie Lovejoy, Jean‐Éric Tremblay, Marianne Potvin, Friederike Heinrich, Marta Estrada, Lasse Riemann, Peer Bork, Carlos Pedrós‐Alió, Stefan Bertilsson	202
19	Pole-to-pole biogeography of surface and deep marine bacterial communities 2012 ·Proceedings of the National Academy of Sciences ·Jean‐François Ghiglione, Pierre E. Galand, Thomas Pommier, Carlos Pedrós‐Alió, Elizabeth W. Maas, Kevin Bakker, (unknown), David L. Kirchman, Connie Lovejoy, Patricia L. Yager, Alison E. Murray	237

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact